| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 434.22M | 298.89M | 215.19M | 208.13M | 217.92M |
| Gross Profit | 249.52M | 123.55M | 125.81M | 115.92M | 128.47M |
| EBITDA | 267.32M | 142.76M | 99.14M | 64.80M | 95.21M |
| Net Income | -9.86M | 58.19M | 36.31M | 20.61M | 30.63M |
Balance Sheet | |||||
| Total Assets | 1.47B | 1.14B | 702.82M | 676.80M | 723.54M |
| Cash, Cash Equivalents and Short-Term Investments | 422.63M | 369.06M | 184.89M | 203.32M | 212.93M |
| Total Debt | 118.48M | 111.98M | 1.31M | 583.00K | 1.26M |
| Total Liabilities | 358.81M | 305.55M | 105.81M | 96.97M | 103.42M |
| Stockholders Equity | 941.67M | 702.73M | 507.25M | 489.05M | 512.40M |
Cash Flow | |||||
| Free Cash Flow | 172.24M | 52.60M | 28.10M | 30.69M | 40.17M |
| Operating Cash Flow | 300.34M | 138.63M | 91.57M | 85.64M | 107.38M |
| Investing Cash Flow | -227.29M | -44.67M | -65.71M | -26.52M | -106.63M |
| Financing Cash Flow | -24.12M | 115.12M | -16.80M | -17.98M | -7.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | C$4.11B | 8.44 | 20.79% | ― | -4.16% | 116.44% | |
78 Outperform | C$976.91M | 4.02 | 20.32% | ― | 67.83% | 342.70% | |
70 Outperform | C$1.04B | 11.29 | 33.35% | ― | 26.70% | 31.54% | |
69 Neutral | C$3.91B | -261.09 | -1.30% | 0.29% | 45.46% | -115.31% | |
67 Neutral | C$4.23B | 33.52 | 20.80% | ― | 313.42% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |